Curcumin is a polyphenolic nutraceutical that acts on multiple biological targets, including protein kinase C (PKC). PKC is a family of serine-threonine kinases central to intracellular signal transduction. We have recently shown that curcumin selectively inhibits PKCα, but not PKCε in CHO-K1 cells (Pany, S. (2016) Biochemistry 55, 2135–43). To understand which domain(s) of PKCα is/are responsible for curcumin binding and inhibitory activity, we made several domain-swapped mutants in which the C1 (combination of C1A and C1B) and C2 domains are swapped between PKCα and PKCε. Phorbol ester-induced membrane translocation studies using confocal microscopy and immune-blotting revealed that curcumin inhibited phorbol ester induced membrane translocation of PKCε mutants, in which εC1 domain was replaced with αC1, but not the PKCα mutant in which αC1 was replaced with εC1 domain, suggesting that αC1 is a determinant for curcumin’s inhibitory effect. Further, curcumin inhibited membrane translocation of PKCε mutants, in which εC1A and εC1B domain were replaced with αC1A and αC1B domains, respectively, indicating the role of both αC1A and αC1B domains in curcumin’s inhibitory effects. Phorbol 13-acetate inhibited curcumin binding to αC1A and αC1B with IC50 values of 6.27 μM and 4.47 μM, respectively. Molecular docking and molecular dynamics studies also supported higher affinity of curcumin for αC1B than αC1A. The C2 domain swapped mutants were inactive in phorbol ester induced membrane translocation. These results indicate that curcumin binds to the C1 domain of PKCα and highlight the importance of this domain in achieving PKC isoform selectivity.